Universal Vision Biotechnology Statistics

Total Valuation

Universal Vision Biotechnology has a market cap or net worth of TWD 18.43 billion. The enterprise value is 17.97 billion.

Market Cap	18.43B
Enterprise Value	17.97B

Important Dates

The next estimated earnings date is Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	Apr 18, 2024

Share Statistics

Universal Vision Biotechnology has 84.72 million shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding	84.72M
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	26.82%
Owned by Institutions (%)	13.62%
Float	46.86M

Valuation Ratios

The trailing PE ratio is 16.77 and the forward PE ratio is 15.56.

PE Ratio	16.77
Forward PE	15.56
PS Ratio	4.42
PB Ratio	5.87
P/FCF Ratio	16.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.83, with an EV/FCF ratio of 16.03.

EV / Earnings	16.32
EV / Sales	4.31
EV / EBITDA	9.83
EV / EBIT	13.27
EV / FCF	16.03

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 26.39.

Current Ratio	2.53
Quick Ratio	2.16
Debt / Equity	26.39
Debt / EBITDA	0.47
Debt / FCF	0.77
Interest Coverage	80.64

Financial Efficiency

Return on equity (ROE) is 35.64% and return on invested capital (ROIC) is 21.61%.

Return on Equity (ROE)	35.64%
Return on Assets (ROA)	16.86%
Return on Capital (ROIC)	21.61%
Revenue Per Employee	10.39M
Profits Per Employee	2.75M
Employee Count	401
Asset Turnover	0.83
Inventory Turnover	5.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.08% in the last 52 weeks. The beta is 0.75, so Universal Vision Biotechnology's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-33.08%
50-Day Moving Average	231.91
200-Day Moving Average	261.13
Relative Strength Index (RSI)	38.80
Average Volume (20 Days)	179,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Universal Vision Biotechnology had revenue of TWD 4.17 billion and earned 1.10 billion in profits. Earnings per share was 12.97.

Revenue	4.17B
Gross Profit	2.50B
Operating Income	1.35B
Pretax Income	1.37B
Net Income	1.10B
EBITDA	1.66B
EBIT	1.35B
Earnings Per Share (EPS)	12.97

Full Income Statement

Balance Sheet

The company has 1.46 billion in cash and 866.02 million in debt, giving a net cash position of 597.91 million or 7.06 per share.

Cash & Cash Equivalents	1.46B
Total Debt	866.02M
Net Cash	597.91M
Net Cash Per Share	7.06
Equity (Book Value)	3.28B
Book Value Per Share	37.08
Working Capital	1.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -422.07 million, giving a free cash flow of 1.12 billion.

Operating Cash Flow	1.54B
Capital Expenditures	-422.07M
Free Cash Flow	1.12B
FCF Per Share	13.23

Full Cash Flow Statement

Margins

Gross margin is 60.03%, with operating and profit margins of 32.52% and 26.44%.

Gross Margin	60.03%
Operating Margin	32.52%
Pretax Margin	32.93%
Profit Margin	26.44%
EBITDA Margin	39.89%
EBIT Margin	32.52%
FCF Margin	26.92%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 3.22%.

Dividend Per Share	7.00
Dividend Yield	3.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	10
Payout Ratio	97.41%
Buyback Yield	-0.08%
Shareholder Yield	3.14%
Earnings Yield	5.96%
FCF Yield	6.08%

Dividend Details

Stock Splits

The last stock split was on August 25, 2023. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 25, 2023
Split Type	Forward
Split Ratio	1.06